Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

for the Neonatal Diabetes International Collaborative Group

doi:10.1016/S2213-8587(18)30106-2

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

for the Neonatal Diabetes International Collaborative Group

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	637-646
Journal	The Lancet Diabetes & Endocrinology
Volume	6
Issue number	8
Early online date	4 Jun 2018
DOIs	https://doi.org/10.1016/S2213-8587(18)30106-2
Publication status	Published - Aug 2018

Keywords / Materials (for Non-textual outputs)

neonatal diabetes
Sulphonylureas

Access to Document

10.1016/S2213-8587(18)30106-2

1-s2.0-S2213858718301062-mainFinal published version, 391 KBLicence: Creative Commons: Attribution (CC-BY)

Cite this

@article{38ba30a531f0499d999ff36e0193d0c7,

title = "Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study",

keywords = "neonatal diabetes, Sulphonylureas",

author = "{for the Neonatal Diabetes International Collaborative Group} and Alan Jaap",

year = "2018",

month = aug,

doi = "10.1016/S2213-8587(18)30106-2",

language = "English",

volume = "6",

pages = "637--646",

journal = "The Lancet Diabetes & Endocrinology",

issn = "2213-8587",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations

T2 - an international cohort study

AU - for the Neonatal Diabetes International Collaborative Group

A2 - Jaap, Alan

PY - 2018/8

Y1 - 2018/8

KW - neonatal diabetes

KW - Sulphonylureas

U2 - 10.1016/S2213-8587(18)30106-2

DO - 10.1016/S2213-8587(18)30106-2

M3 - Article

SN - 2213-8587

VL - 6

SP - 637

EP - 646

JO - The Lancet Diabetes & Endocrinology

JF - The Lancet Diabetes & Endocrinology

IS - 8

ER -